Impact of HLA alloimmunization in gene-modified autologous stem cell transplant for transfusion-dependent thalassemia
- PMID: 40089998
- DOI: 10.1182/blood.2024027034
Impact of HLA alloimmunization in gene-modified autologous stem cell transplant for transfusion-dependent thalassemia
Abstract
We report our single-center experience demonstrating that HLA class I alloimmunization predicts longer time to platelet engraftment, increased bleeding complications, and higher transfusion requirements in patients undergoing gene-modified hematopoietic stem cell transplant for transfusion-dependent β thalassemia.
© 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Comment in
-
HLA antibodies delay platelet recovery after gene therapy.Blood. 2025 May 29;145(22):2546-2547. doi: 10.1182/blood.2025028995. Blood. 2025. PMID: 40440042 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials

